三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
多靶点TKI类药物是常见的晚期肝癌一线治疗方式
多靶点TKI类药物是常见的晚期肝癌一线治疗方式
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:523KB
图片尺寸:1735*892
同报告图片
/
4
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
所属报告:
泽璟制药-公司首次覆盖报告:国内biotech领航者即将步入创新药密集收获期-240702(32页).pdf
打包全文图表
相关数据
全球ADC及生物偶联药物CRDMO市场规模(亿美元)
fCDlubTku70gfCDluILlnLrop4TmqKHvvIjkur/nvo7lhYPvvIkgfAp8IDotLS0gfCA6LS0tIHwKfCAyMDE4QSB8IDUgfAp8IDIwMTlBIHwgNiB8CnwgMjAyMEEgfCA4IHwKfCAyMDIxQSB8IDExIHwKfCAyMDIyQSB8IDE1IHwKfCAyMDIzRSB8IDIwIHwKfCAyMDI0RSB8IDI2IHwKfCAyMDI1RSB8IDM1IHwKfCAyMDI2RSB8IDQ2IHwKfCAyMDI3RSB8IDU5IHwKfCAyMDI4RSB8IDc1IHwKfCAyMDI5RSB8IDkyIHwKfCAyMDMwRSB8IDExMCB8CgoqKui1hOaWmeadpea6kO+8mioqIEZyb3N0JlN1bGxpdmFu77yM6I2v5piO5ZCI6IGU5oub6IKh5Lmm77yM5Zu95L+h6K+B5Yi457uP5rWO56CU56m25omA5pW055CG
收藏
市场规模
2026-07-22
原图定位
查看详情
全球寡核苷酸药物CDMO市场规模(亿美元)
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
收藏
市场规模
2026-07-22
原图定位
查看详情
表1、历次国家基本药物目录总体情况
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
收藏
行业数据
2026-07-16
原图定位
查看详情
国内部分在研单胺神经递质靶点抗抑郁药(截至2026年7月7日)
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
收藏
行业数据
2026-07-14
原图定位
查看详情
2019-2023国内芬太尼药物销售额(亿元)
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
收藏
行业数据
2026-07-14
原图定位
查看详情
2019-2023国内全身麻醉药物市场规模(单位:亿元)
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
收藏
市场规模
2026-07-14
原图定位
查看详情
2023国内全身麻醉药物竞争格局
fCDoja/nianlkI3np7AgfCDljaDmr5QgICB8CnwtLS0tLS0tLS0tfC0tLS0tLS0tfAp8IOS4meaziumFmiAgIHwgMzUuODElIHwKfCDkuIPmsJ/ng7cgICB8IDMwLjc2JSB8Cnwg5L6d5omY5ZKq6YWvIHwgMTEuNzElIHwKfCDnjq/ms4rphZogICB8IDkuOTQlICB8Cnwg5YW25LuWICAgICB8IDExLjc4JSB8CgrotYTmlpnmnaXmupDvvJrmkannhrXljLvoja/vvIzopb/pg6jor4HliLjnoJTlj5HkuK3lv4M=
收藏
竞争格局
2026-07-14
原图定位
查看详情
康臣药业肾科药物收入增长情况,2020-2025年CAGR=15.56%
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
收藏
行业数据
2026-07-03
原图定位
查看详情
MASH药物开发格局
收藏
竞争格局
2026-07-01
原图定位
查看详情
图表232025年肿瘤免疫融资事件中的药物类型构成
fCDoja/niannsbvlnosgICAgICAgfCDmlbDph48gfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS18Cnwg57uG6IOe55aX5rOVICAgICAgIHwgNjIgICB8Cnwg5Y+ML+WkmuaKlyAgICAgICAgfCAyNCAgIHwKfCDmsrvnlpfmgKfogr/nmKTnlqvoi5cgfCAxNCAgIHwKfCDljZXmipcgICAgICAgICAgIHwgNiAgICB8Cnwg57uG6IOe5Zug5a2Q55aX5rOVICAgfCAzICAgIHwKfCDmurbnmKTnl4Xmr5Lnlpfms5UgICB8IDEgICAgfAoK6LWE5paZ5p2l5rqQ77ya5pqC5pyq5piO56Gu77yI6ZyA5qC55o2u5Zu+6KGo5Y6f5aeL5Ye65aSE6KGl5YWF77yJ
收藏
行业数据
2026-06-15
原图定位
查看详情
国内部分IL-17靶点药物研发进展(截至2026年6月12日)
收藏
行业数据
2026-06-15
原图定位
查看详情
图表21骨骼肌肉疾病药物中成药市场规模
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
收藏
市场规模
2026-06-05
原图定位
查看详情
中国降血脂药物市场规模
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
收藏
市场规模
2026-05-28
原图定位
查看详情
全球(中国以外)降血脂药物市场规模
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
收藏
市场规模
2026-05-28
原图定位
查看详情
PCSK9药物研发格局(筛选全球最高研发阶段进入III期的活跃管线)
PHRhYmxlIGJvcmRlcj0iMSIgY2VsbHNwYWNpbmc9IjAiIGNlbGxwYWRkaW5nPSI1Ij4KICAgIDx0aGVhZD4KICAgICAgICA8dHIgc3R5bGU9ImJhY2tncm91bmQtY29sb3I6ICMwMGEyZTg7IGNvbG9yOiB3aGl0ZTsiPgogICAgICAgICAgICA8dGg+6I2v54mp5ZCN56ewPC90aD4KICAgICAgICAgICAgPHRoPumdtueCuTwvdGg+CiAgICAgICAgICAgIDx0aD7kvZznlKjmnLrliLY8L3RoPgogICAgICAgICAgICA8dGg+5Lit5Zu956CU5Y+R6LWb6YGT5o6S5ZCNPC90aD4KICAgICAgICAgICAgPHRoPuWFqOeQg+eglOWPkei1m+mBk+aOkuWQjTwvdGg+CiAgICAgICAgICAgIDx0aD7noJTlj5HmnLrmnoQ8L3RoPgogICAgICAgICAgICA8dGg+5YWo55CD5pyA6auY56CU5Y+R6Zi25q61PC90aD4KICAgICAgICAgICAgPHRoPuWFqOeQg+acgOmrmOeglOWPkemYtuauteW8gOWni+aXpeacnzwvdGg+CiAgICAgICAgICAgIDx0aD7kuK3lm73mnIDpq5jnoJTlj5HpmLbmrrU8L3RoPgogICAgICAgICAgICA8dGg+5Lit5Zu95pyA6auY56CU5Y+R6Zi25q615byA5aeL5pel5pyfPC90aD4KICAgICAgICA8L3RyPgogICAgPC90aGVhZD4KICAgIDx0Ym9keT4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7ojrHovr7opb/otJ3mma48L3RkPgogICAgICAgICAgICA8dGQ+YWxidW1pbjtQQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5hbGJ1bWluw5dQQ1NLOeiejeWQiOibi+eZvTtQQ1NLOeaKkeWItuWJgjwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzE8L3RkPgogICAgICAgICAgICA8dGQ+MS8xPC90ZD4KICAgICAgICAgICAgPHRkPuS6kemhtuaWsOiAgDtMaWIgVGhlcmFwZXV0aWNzO+a1t+ajrueUn+eJqTwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0xMi0xMjwvdGQ+CiAgICAgICAgICAgIDx0ZD5JSUnmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNC0wNi0yMTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7nkZ7ljaHopb/ljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+YW50aS1QQ1NLOeWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD42Lzk8L3RkPgogICAgICAgICAgICA8dGQ+Ni85PC90ZD4KICAgICAgICAgICAgPHRkPuaBkueRnuWMu+iNrzwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wMS0wODwvdGQ+CiAgICAgICAgICAgIDx0ZD7mibnlh4bkuIrluII8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNS0wMS0wODwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD7mmILmiIjnkZ7opb/ljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+YW50aS1QQ1NLOeWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD41Lzk8L3RkPgogICAgICAgICAgICA8dGQ+NS85PC90ZD4KICAgICAgICAgICAgPHRkPuWQm+WunueUn+eJqTvmpI3mgannlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMTAtMDk8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMTAtMDk8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5LyK5Yqq6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+NC85PC90ZD4KICAgICAgICAgICAgPHRkPjQvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7lurfono3kuJzmlrk8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMDktMjY8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjQtMDktMjY8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5omY6I6x6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+My85PC90ZD4KICAgICAgICAgICAgPHRkPjMvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7kv6Hovr7nlJ/niak7QWRpbWFiPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTE1PC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTE1PC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPuiLseWFi+WPuOWFsDwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5zaVJOQeeWl+azlTwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzI3PC90ZD4KICAgICAgICAgICAgPHRkPjEvMjc8L3RkPgogICAgICAgICAgICA8dGQ+VGhlIE1lZGljaW5lcyBDb21wYW55O0FsbnlsYW0gUGhhcm1hY2V1dGljYWxzPC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIwLTEyLTA5PC90ZD4KICAgICAgICAgICAgPHRkPuaJueWHhuS4iuW4gjwvdGQ+CiAgICAgICAgICAgIDx0ZD4yMDIzLTA4LTIyPC90ZD4KICAgICAgICA8L3RyPgogICAgICAgIDx0cj4KICAgICAgICAgICAgPHRkPumYv+WIqeilv+WwpOWNleaKlzwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5hbnRpLVBDU0s55Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPjIvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD4yLzk8L3RkPgogICAgICAgICAgICA8dGQ+U2Fub2ZpO1JlZ2VuZXJvbiBQaGFybWFjZXV0aWNhbHM8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTUtMDctMjQ8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTktMTItMjY8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5L6d5rSb5bCk5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+MS85PC90ZD4KICAgICAgICAgICAgPHRkPjEvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5BbWdlbjtBc3RlbGxhcyBQaGFybWE8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTUtMDctMTc8L3RkPgogICAgICAgICAgICA8dGQ+5om55YeG5LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMTgtMDctMTA8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+5rOw5Y2h6KW/5Y2V5oqXPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPmFudGktUENTSznljZXmipc8L3RkPgogICAgICAgICAgICA8dGQ+Ny85PC90ZD4KICAgICAgICAgICAgPHRkPjcvOTwvdGQ+CiAgICAgICAgICAgIDx0ZD7kv6Hnq4vms7A8L3RkPgogICAgICAgICAgICA8dGQ+55Sz6K+35LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDktMTk8L3RkPgogICAgICAgICAgICA8dGQ+55Sz6K+35LiK5biCPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDktMTk8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+U1IwNDM8L3RkPgogICAgICAgICAgICA8dGQ+UENTSzk8L3RkPgogICAgICAgICAgICA8dGQ+c2lSTkHnlpfms5U8L3RkPgogICAgICAgICAgICA8dGQ+My8yNzwvdGQ+CiAgICAgICAgICAgIDx0ZD4zLzI3PC90ZD4KICAgICAgICAgICAgPHRkPum9kOmygeWItuiNrzvnkZ7ljZrnlJ/niak8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjYtMDItMjc8L3RkPgogICAgICAgICAgICA8dGQ+SUnmnJ/kuLTluoo8L3RkPgogICAgICAgICAgICA8dGQ+MjAyNC0xMi0xOTwvdGQ+CiAgICAgICAgPC90cj4KICAgICAgICA8dHI+CiAgICAgICAgICAgIDx0ZD5TWUgyMDUzPC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPnNpUk5B55aX5rOVPC90ZD4KICAgICAgICAgICAgPHRkPjIvMjc8L3RkPgogICAgICAgICAgICA8dGQ+Mi8yNzwvdGQ+CiAgICAgICAgICAgIDx0ZD7nn7Poja/pm4blm6I8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMTItMTU8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMTItMTU8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+bGFyb3Byb3ZzdGF0PC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s5PC90ZD4KICAgICAgICAgICAgPHRkPlBDU0s55oqR5Yi25YmCPC90ZD4KICAgICAgICAgICAgPHRkPjIvMTc8L3RkPgogICAgICAgICAgICA8dGQ+Mi8xNzwvdGQ+CiAgICAgICAgICAgIDx0ZD5Bc3RyYVplbmVjYTtEb2dtYSBUaGVyYXBldXRpY3M8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDYtMDI8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjUtMDYtMDI8L3RkPgogICAgICAgIDwvdHI+CiAgICAgICAgPHRyPgogICAgICAgICAgICA8dGQ+ZW5saWNpdGlkZTwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOTwvdGQ+CiAgICAgICAgICAgIDx0ZD5QQ1NLOeaKkeWItuWJgjwvdGQ+CiAgICAgICAgICAgIDx0ZD4xLzE3PC90ZD4KICAgICAgICAgICAgPHRkPjEvMTc8L3RkPgogICAgICAgICAgICA8dGQ+TWVyY2sgJiBDby48L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDctMTk8L3RkPgogICAgICAgICAgICA8dGQ+SUlJ5pyf5Li05bqKPC90ZD4KICAgICAgICAgICAgPHRkPjIwMjMtMDctMTk8L3RkPgogICAgICAgIDwvdHI+CiAgICA8L3Rib2R5Pgo8L3RhYmxlPgoKPHA+6LWE5paZ5p2l5rqQ77ya5Yy76I2v6a2U5pa577yI5oiq5q2iMjAyNi8wNC8yMe+8ie+8jOWbveazsOa1t+mAmuivgeWIuOeglOeptjwvcD4=
收藏
竞争格局
2026-05-28
原图定位
查看详情
最新数据
开源模型参数规模在今年4月开始突破
收藏
市场规模
2026-08-03
原图定位
查看详情
不同任务中,推理模式相比普通模式的token消耗倍数范围
收藏
商业模式
2026-08-03
原图定位
查看详情
全球专业开发者规模(百万人)
收藏
市场规模
2026-08-03
原图定位
查看详情
中国汽车出口政策由规模导向转向高质量发展
收藏
政策法规
2026-08-03
原图定位
查看详情
营收四年CAGR近39%,8000亿规模持续创新高
收藏
市场规模
2026-08-03
原图定位
查看详情
由于肝癌起病隐匿,首次诊断时只有不到 30%的肝癌病人适合接受根治性治疗,系统抗肿瘤治疗在中晚期肝癌的治疗过程中发挥重要的作用。系统治疗(或称为全身性治疗),主要指抗肿瘤治疗,包括分子靶向药物治疗、免疫检查点抑制剂治疗、化学治疗和中医中药治疗等。针对晚期肝癌一线治疗,目前常用的治疗方式有多靶点 TKI 类药物(包括索拉非尼、仑伐替尼与多纳非尼)、基于 PD(L)-1 的免疫联合治疗方案;针对不同的一线治疗方案,主流的二线治疗药物包括瑞戈非尼、阿帕替尼以及 PD-1单抗等。
其它
原图定位
当前图表所属:
泽璟制药-公司首次覆盖报告:国内biotech领航者即将步入创新药密集收获期-240702(32页).pdf
泽普凝有望凭借优异的安全性和止血效果,占据更多市场份额
重组人凝血酶用于肝段切除术中辅助止血的1/2期临床试验止血效果优异
仑伐替尼及索拉非尼已有多个仿制药被纳入第四批、第七批集采
公司积极布局多纳非尼与免疫疗法联用治疗实体瘤
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》